This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
—In the article entitled "Argon Laser Photocoagulation for Neovascular Maculopathy: Five-Year Results from Randomized Clinical Trials" published in the August 1991 issue of the Archives (1991;109:1109-1114), the 1.5-month (6-week) recurrence rates were omitted from Fig 4 for all three groups of laser-treated eyes (the legend for Fig 4 was correct, however). Figure 4 is correct as printed on the right.
In addition, a statement in the "Patients and Methods" section was incorrect. On page 1110, the third paragraph in the left column should start as follows: "Recurrent neovascularization contiguous with laser treatment scars (recurrence) was defined as visible leakage of fluorescein dye along the border of a laser treatment scar during fluorescein angiography after treatment.5 The time of the recurrence was classified as the time of the scheduled visit at which the recurrence was noted or, whenever the recurrence was discovered between scheduled visits, the last such visit before
Figure and Statement Incorrect. Arch Ophthalmol. 1992;110(6):761. doi:10.1001/archopht.1992.01080180031023
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: